> Following GlaxoSmithKline's ($GSK) lead, Roche ($RHHBY) has agreed to give researchers access to anonymized clinical trial data for all its approved products. Article
> In the 16 months leading up to its IPO filing, Quintiles spent more than $280 million on acquisitions to boost its presence in the CRO world. Story
> Pharma Tech Industries has signed on to provide filling, assembly and packaging for OptiNose's nasally delivered migraine treatment. News
> Xceleron is partnering with consulting outfit Kinetigen to offer simple, robust Phase I clinical investigations to its clients. More
> CMO Althea Technologies has inked a deal with Profectus BioSciences to manufacture the company's DNA vaccines. Item